Compare Nebius Group NV (NBIS) vs Pfizer Inc (PFE) Price & Performance

Nebius Group NVTrade

Pfizer IncTrade

Price performance (Past 24H)

Key statistics

Nebius Group NV vs Pfizer Inc — how do they compare? Nebius Group NV trades at $219.4 (market cap $46.37B), while Pfizer Inc trades at $24.92 (market cap $141.06B). The key difference: Pfizer Inc is far larger — about 3× Nebius Group NV's market cap, and Pfizer Inc pays a 6.95% dividend while Nebius Group NV pays none. Which is the better fit depends on your goals.

	NBIS	PFE
Market Cap	$46.37B	$141.06B
Sector	Technology	Health
52-Week High	$286.69	$28.56
52-Week Low	$50.40	$23.29
Enterprise Value	$46.56B	$191.72B
Volume	—	29,869,932
Dividend Yield	—	6.95%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nebius Group NV

No Aura AI signal available yet.

Pfizer Inc

Pfizer (PFE) trades at $25.05, down 0.36% on the day, with a bullish technical signal supported by strong quarterly earnings beats. The company maintains solid profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated post-pandemic. Recent news highlights pipeline advancements in oncology and obesity treatments, positioning PFE for potential growth catalysts in 2026.

The outlook for Pfizer is cautiously optimistic, with a consensus price target of $28.25 offering 13% upside. Key opportunities include dividend stability and pipeline innovation, while risks involve patent cliffs and competitive pressures. Analyst sentiment is mixed with 38% buy ratings, reflecting balanced views on recovery potential versus near-term challenges.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NBIS

Nebius shares jump 13% after Nvidia reveals 9.3% stake, deepening AI partnership.Proactive Investors · 9 hours agoBullish Nvidia invests $2B in Nebius, Samsung launches Galaxy Card, Cracker Barrel beats revenue outlook.Seeking Alpha · 14 hours agoBullish Nebius shares jump as Nvidia reveals 9.3% stake in Dutch AI cloud companyCNBC · 15 hours agoBullish View details →

PFE

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 4 hours agoBullish New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Nebius Group NV

Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.